Protease-activated receptor 1 as potential therapeutic target in pulmonary arterial hypertension

Daphne Merkus*, H.M.M. van Beusekom, KA Boomars

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

2 Citations (Scopus)
1 Downloads (Pure)

Abstract

This editorial refers to ‘Proteinase-activated receptor 1 antagonism ameliorates experimental pulmonary hypertension’, by Y. Kuwabara et al., pp. 1357–1368
Original languageEnglish
Pages (from-to)1260-1261
Number of pages2
JournalCardiovascular Research
Volume115
Issue number8
Early online date23 Mar 2019
DOIs
Publication statusPublished - 1 Jul 2019

Bibliographical note

Published on behalf of the European Society of Cardiology. All rights reserved. Copyright: The Author(s) 2019

Research programs

  • EMC COEUR-09

Fingerprint

Dive into the research topics of 'Protease-activated receptor 1 as potential therapeutic target in pulmonary arterial hypertension'. Together they form a unique fingerprint.

Cite this